Law360, New York (January 11, 2018, 3:37 PM EST) — Sanofi reasonably filed a patent for its insulin injector in the FDA’s Orange Book, since the agency wasn’t clear about whether it should, and rationally defended that patent against possible infringement, a Massachusetts federal magistrate judge …
